Morgan Stanley »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Morgan Stanley

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.4M 10M 0.94
2023-09-30 $9.9M 11M 0.92

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Calamos Advisors
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1